|
The number of outstanding shares of the registrant?s common stock was 119,014,093 as of March 12, 2019.
Da stehen noch über 40 Mio Aktien, fast alle im Geld! Das werden mit Sicherheit noch mehr, wenn die sich untereinander verdünnen.
BIN DANN MAL WEG!!!!!!!!!
As of December 31, 2018, we had outstanding the following securities that are convertible into or exercisable for shares of our common stock:
?
options to purchase an aggregate of 120,000 shares of our common stock issued to our officers, directors, employees and non-employee consultants under our Amended and Restated 2006 Stock Incentive Plan, or the 2006 Stock Plan, with a weighted average exercise price of $1.44 per share;
?
options to purchase an aggregate of 4,936,326 shares of our common stock issued to our officers, directors and non-employee consultants under our 2013 Stock Plan, with a weighted average exercise price of $1.87 per share;
?
warrants for 500,000 shares of common stock issued in May 2013 with an exercise price of $0.001 per share that expire on May 30, 2019;
?
warrants for 750,000 shares of common stock with an exercise price of $0.001 that expire on October 22, 2019;
?
warrants for 725,000 shares of common stock with an exercise price of $0.90 that expire on January 8, 2020;
?
Series C-2 Preferred Stock convertible into 1,500,000 shares of common;
?
Series C-3 Preferred Stock convertible into 1,040,000 shares of common stock;
?
Series D Preferred Stock convertible into 1,479,240 shares of common stock;
?
Series E Preferred Stock convertible into 1,959,759 shares of common stock;
?
Series F Preferred Stock convertible into 12,345,679 shares of common stock, subject to adjustment;
?
warrants for 682,500 shares of common stock issued in March 2014 with an exercise price of $2.50 per share that expire on September 10, 2019;
?
warrants for 200,000 shares of common stock with an exercise price of $7.00 that expire on March 3, 2020;
?
warrants for 83,400 shares of common stock with an exercise price of $7.00 that expire on March 25, 2020;
?
Series B warrants for 11,974,839 shares of common stock with an exercise price of $1.05 that expire on August 10, 2022;
?
underwriter warrants for 664,419 shares of common stock with an exercise price of $0.9375 that expire on August 10, 2022;
?
warrants for 564,858 shares of common stock with an exercise price of $0.001 that expire on November 16, 2020;
?
warrants for 450,000 shares of common stock with an exercise price of $1.50 that expire on December 31, 2023;
?
Senior convertible note convertible into 5,000,000 shares of common stock; and
?
restricted stock units for 29,087 shares of common stock with an average grant date fair value of $2.08 per share.
|
Thread abonnieren
